ID

34178

Descripción

VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT02392455

Link

https://clinicaltrials.gov/show/NCT02392455

Palabras clave

  1. 15/1/19 15/1/19 -
  2. 14/5/19 14/5/19 -
Titular de derechos de autor

GSK group of companies

Subido en

15 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455

Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 or older
Descripción

ID.1

Tipo de datos

boolean

men and women locally advanced, metastastic and/or recurrent nsclc with adenocarcinoma histology for which vargatef treatment is indicated according to summary of product characteristics (smpc)
Descripción

ID.2

Tipo de datos

boolean

after first line therapy; second-line therapy not yet started
Descripción

ID.3

Tipo de datos

boolean

standard 21-day-cycles docetaxel treatment according to smpc possible
Descripción

ID.4

Tipo de datos

boolean

written informed consent
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications according to the smpc of vargatef or docetaxel
Descripción

ID.6

Tipo de datos

boolean

more than one systemic therapy for treatment of nsclc in palliative setting
Descripción

ID.7

Tipo de datos

boolean

current partcipation in another non-interventional study or a clinical trial
Descripción

ID.8

Tipo de datos

boolean

pregnancy
Descripción

ID.9

Tipo de datos

boolean

breastfeeding
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT02392455

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age 18 or older
boolean
ID.2
Item
men and women locally advanced, metastastic and/or recurrent nsclc with adenocarcinoma histology for which vargatef treatment is indicated according to summary of product characteristics (smpc)
boolean
ID.3
Item
after first line therapy; second-line therapy not yet started
boolean
ID.4
Item
standard 21-day-cycles docetaxel treatment according to smpc possible
boolean
ID.5
Item
written informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
contraindications according to the smpc of vargatef or docetaxel
boolean
ID.7
Item
more than one systemic therapy for treatment of nsclc in palliative setting
boolean
ID.8
Item
current partcipation in another non-interventional study or a clinical trial
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
breastfeeding
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial